AbbVie vs General Motors: Founders, CEOs and History
AbbVie was founded in 2013 by Abbott Laboratories (spin-off origin) and is led by Robert A. Michael. General Motors was founded in 1908 by William C. Durant and is led by Mary Barra.
Company facts
AbbVie
- Founded
- 2013
- Headquarters
- North Chicago, Illinois
- Current CEO
- Robert A. Michael
- Employees
- 57,000
General Motors
- Founded
- 1908
- Headquarters
- Detroit, Michigan
- Current CEO
- Mary Barra
- Employees
- 155,000
Founders
AbbVie
Abbott Laboratories (spin-off origin)
Abbott Laboratories was AbbVie's corporate predecessor. AbbVie's official launch materials describe the company as formed in 2013 following separation from Abbott. Richard A.
General Motors
William C. Durant
General Motors possesses one of the most chaotic, and consequential founding stories in American business history, built entirely through the aggressive, acquisitions of a single, effective, flawed visionary.
CEOs and their tenures
AbbVie
- Richard A. Gonzalez2013–2024
Founding Chairman and Chief Executive Officer
Served as AbbVie's chief executive officer from its formation in 2013 through June 2024 and as executive chairman through June 2025.
Source - Robert A. Michael2024–present
Chairman and Chief Executive Officer
Became chief executive officer on July 1, 2024 and chairman on July 1, 2025. He previously led finance, commercial operations, and corporate strategy roles at AbbVie.
Source
General Motors
- Alfred P. Sloan1923–1956
Former President, CEO, and Chairman
Sloan is arguably the most influential corporate executive of the twentieth century.
Source - Rick Wagoner2000–2009
Former Chairman and CEO
Wagoner's tenure ended in historic disaster, culminating in the 2009 government-managed bankruptcy and his forced resignation by the Obama administration.
Source - Mary Barra2014–present
Chair and Chief Executive Officer
Under Barra, GM has focused on profitability over global volume, regained the top U.S. sales spot, and returned large amounts of cash to shareholders through buybacks.
Source - Paul Jacobson2020–present
Executive Vice President and Chief Financial Officer
Has emphasized cash generation, inventory and incentive discipline, and returning North America margins to the 8-10% range.
Source - Mark Reuss2020–present
President
Longtime GM product and engineering executive who previously led global product development.
Source - Sterling Anderson2025–present
Executive Vice President and Chief Product Officer
Leads GM's in-house autonomous-driving effort after the end of Cruise robotaxi funding.
Source
Timeline: AbbVie and General Motors side by side
1908General Motors
General Motors Founded
William C. Durant incorporates General Motors in Hudson, New Jersey, on September 16, 1908, with Buick Motor Company as its primary asset.
1909General Motors
Cadillac and Oldsmobile Acquired
GM acquires Oldsmobile and the prestigious Cadillac Automobile Company, establishing the multi-brand architecture that will define GM's market segmentation strategy for decades.
1923General Motors
Alfred Sloan Becomes President
Alfred P. Sloan takes the GM presidency and begins implementing the decentralized divisional management structure and market segmentation strategy that transforms GM into the world's most admired corporate organization.
1931General Motors
GM Surpasses Ford as World's Largest Automaker
General Motors overtakes Ford Motor Company as the world's largest automobile manufacturer by sales volume, a position it would hold for the majority of the next seven decades.
1984General Motors
Saturn Corporation Founded
GM establishes Saturn as a separate subsidiary intended to compete with Japanese small cars through innovative labor relations, retail practices, and manufacturing processes.
1996General Motors
OnStar Connected Vehicle Service Launched
GM introduces OnStar, the world's first embedded cellular connected vehicle service, offering emergency assistance, stolen vehicle tracking, and remote diagnostics.
2009General Motors
Chapter 11 Bankruptcy and Government Bailout
General Motors files for Chapter 11 bankruptcy protection on June 1, 2009, with $49.5 billion in U.S. Government assistance as part of the Troubled Asset Relief Program.
2010General Motors
IPO Return to Public Markets
General Motors returns to public markets through an initial public offering on November 18, 2010, raising approximately $23.1 billion - at the time one of the largest IPOs in U.S. History. The offering allows the U.S.
2013AbbVie
AbbVie Launches as an Independent Company
AbbVie launched after Abbott Laboratories separated its research-based pharmaceutical business and began NYSE trading under ABBV.
2014General Motors
Mary Barra Becomes CEO
Mary Barra, a 33-year GM veteran with a background in engineering and manufacturing, becomes CEO on January 15, 2014, becoming the first female CEO of a major global automaker.
2015AbbVie
Pharmacyclics Acquisition Completed
AbbVie completed its acquisition of Pharmacyclics, adding Imbruvica and expanding its hematologic oncology business.
2016General Motors
Cruise Automation Acquired
GM acquires Cruise Automation, a San Francisco-based autonomous vehicle startup, for approximately $1 billion - at the time one of the largest acquisitions in GM's modern history.
2019AbbVie
Skyrizi Receives Initial U.S. Approval
The FDA approved Skyrizi for adults with moderate to severe plaque psoriasis in April 2019.
2019AbbVie
Rinvoq Receives Initial U.S. Approval
The FDA approved Rinvoq for adults with moderate to severe rheumatoid arthritis in August 2019.
2020AbbVie
Allergan Acquisition Completed
AbbVie completed the Allergan acquisition, adding neuroscience, eye care, and Allergan Aesthetics products including Botox and Juvederm.
2021General Motors
Ultium Platform and EV Commitment Announced
GM announces its commitment to invest more than $35 billion in electric and autonomous vehicles through 2025 and introduces the Ultium battery platform as the technological foundation for dozens of future EV models across all four U.S. Brands.
2023AbbVie
U.S. Humira Biosimilar Competition Begins
Humira began facing U.S. biosimilar competition, and AbbVie reported a subsequent decline in Humira revenue.
2024AbbVie
ImmunoGen Acquisition Completed
AbbVie completed its acquisition of ImmunoGen, adding Elahere and antibody-drug conjugate programs.
2024AbbVie
Robert A. Michael Becomes CEO
Robert A. Michael succeeded Richard A. Gonzalez as chief executive officer effective July 1, 2024.
2024AbbVie
Cerevel Therapeutics Acquisition Completed
AbbVie completed its acquisition of Cerevel Therapeutics, adding clinical-stage neuroscience programs.
2024General Motors
Cruise Robotaxi Program Ended
Following the October 2023 Cruise pedestrian incident and a long operational pause, GM announced in December 2024 that it would stop funding Cruise's robotaxi business and fold the unit's technology work into GM.
2025AbbVie
Robert A. Michael Becomes Chairman
Robert A. Michael added the chairman role effective July 1, 2025, when Richard A. Gonzalez retired from the board.
2025AbbVie
FY2025 Revenue Reaches $61.160 Billion
AbbVie reported FY2025 net revenue of $61.160 billion and net income of $4.226 billion.
2025General Motors
EV Capacity Cut and $7.6 Billion in EV Charges
After the U.S. federal EV tax credit expired on September 30, 2025, GM cut EV production capacity and recorded about $7.6 billion of EV-related charges for the year.
2026AbbVie
Q1 2026 Revenue Reaches $15.002 Billion
AbbVie reported first-quarter 2026 net revenue of $15.002 billion, up 12.4 percent on a reported basis.
2026General Motors
Guidance Raised as North America Margins Recover
GM reported Q2 2026 revenue of $48.0 billion and EBIT-adjusted of $3.9 billion, with North America margins back in its 8-10% target range, and raised full-year 2026 EBIT-adjusted guidance to $14.0-16.0 billion.
Acquisitions
AbbVie
- ImmunoGen, Inc.2024$10.1B
- Cerevel Therapeutics2024$8.7B
- Allergan plc2020$63B
- Pharmacyclics, Inc.2015$21B
General Motors
- Cruise Automation2016$1B
- Buick Motor Company (Original Acquisition)1908Undisclosed
Questions about AbbVie vs General Motors
Who is the CEO of AbbVie Inc. and General Motors Company?
AbbVie Inc. is led by Robert A. Michael and General Motors Company is led by Mary Barra. Both serve as the top executive responsible for the company's strategy, operations, and financial performance.
When was AbbVie Inc. founded vs General Motors Company?
General Motors Company was founded in 1908 — 105 years before AbbVie Inc., which was founded in 2013. General Motors Company's longer operating history gives it a deeper track record but also potentially more institutional inertia compared to the younger AbbVie Inc..
How many employees does AbbVie Inc. have compared to General Motors Company?
AbbVie Inc. employs approximately 57,000 people, while General Motors Company employs approximately 155,000. General Motors Company has the larger workforce at 155,000 employees, compared to AbbVie Inc.'s 57,000. A higher headcount does not necessarily imply greater efficiency — it often reflects differences in business model (e.g., manufacturing vs. software).
Where are AbbVie Inc. and General Motors Company headquartered?
Both AbbVie Inc. and General Motors Company are headquartered in United States, meaning they operate under the same primary regulatory and tax environment.
Who founded AbbVie Inc. and General Motors Company?
AbbVie Inc. was founded by Abbott Laboratories (spin-off origin). General Motors Company was founded by William C. Durant.
Which company has a longer operating history — AbbVie Inc. or General Motors Company?
General Motors Company has been operating for approximately 118 years, making it the more established of the two companies. AbbVie Inc. has been in operation for around 13 years. A longer operating history often signals greater institutional resilience and brand recognition, though it can also mean slower adaptation to new market conditions.
Figures come from each company's filings and the sources linked beside them. Amounts reported in another currency are shown in US dollars at an approximate rate and marked with ~. Back to the AbbVie vs General Motors overview